German life sciences major Bayer beat consensus estimates with its sales in the second quarter of 2022, with the 12.82 billion euros ($13 billion) total represe 4 August 2022
Janssen Pharmaceuticals has announced the appointment of Maria Walsh as business unit director, oncology and hematology, cell and gene therapy and pulmonary hyp 27 July 2022
Dutch firm NewAmsterdam Pharma Holding and Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company (SPAC) sponsored by an affiliate 26 July 2022
Novartis has reported slightly lower than expected revenues for the second quarter, coming in at $12.78 billion dollars, a 1% decline from the same period of la 19 July 2022
Advocate General Juliane Kokott, an adviser to the Court of Justice of the European Union, has urged the court to find that a series of pay-for-delay deals agre 15 July 2022
German central nervous system (CNS) specialist Neuraxpharm is to buy two product portfolios within its main therapeutic focus area from French vaccines major Sa 12 July 2022
Shares in Minneapolis-based DiaMedica Therapeutics, a biopharma focused on developing novel treatments for neurological disorders and kidney diseases, were down 7 July 2022
French pharma major Sanofi has launched a new nonprofit project designed to help at-risk populations in the world’s least developed countries. 4 July 2022
One UK-based company is looking to transform the way metabolic disorders are treated, leveraging many of the same AI-based techniques used to great effect elsew 4 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.